US FDA Grants VistaGen Therapeutics Fast Track Designation for PH94B for Treatment of Social Anxiety Disorder - GuruFocus.com

Submitted by Anonymous (not verified) on Tue, 12/10/2019 - 17:05

US FDA Grants VistaGen Therapeutics Fast Track Designation for PH94B for Treatment of Social Anxiety Disorder  GuruFocus.com